Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Monoclonal Antibody
100%
Rhabdomyosarcoma
100%
Xenograft
60%
Cell Surface
40%
Tumor Uptake
40%
Binding Site
20%
Lung
20%
Liver
20%
Spleen
20%
Radiotherapy
20%
Kidney
20%
Chemotherapy
20%
Injected Dose
20%
Biodistribution
20%
Intravenous Injection
20%
Radioimmunotherapy
20%
After Injection
20%
Tumor Tissue
20%
Binding Studies
20%
Tumor Antigen
20%
IgG1 Monoclonal Antibody
20%
Multiple Injections
20%
Mesenchymal Tumor
20%
Iodine-131 (131I)
20%
Athymic Mice
20%
Femur
20%
Rhabdomyosarcoma Cells
20%
In Vitro Characterization
20%
Saturation Binding
20%
Clinical Role
20%
Metastatic Rhabdomyosarcoma
20%
Immunotargeting
20%
Epithelial Tumors
20%
Neuroectodermal Tumor
20%
Medicine and Dentistry
Monoclonal Antibody
100%
Rhabdomyosarcoma
100%
Iodine 125
83%
Neoplasm
50%
Xenograft
50%
Cell Surface
33%
Injection
33%
In Vitro
16%
Binding Site
16%
Tumor Antigen
16%
Internalization
16%
Biodistribution
16%
Iodine 131
16%
Radioimmunotherapy
16%
Immunoglobulin G1
16%
Rhabdomyosarcoma Cell Line
16%
Lung
16%
Chemotherapy
16%
Radiation Therapy
16%
Tumor
16%
Intravenous Injection
16%
Immunology and Microbiology
Monoclonal Antibody
100%
Iodine-125
100%
Xenograft
60%
Cell Surface
40%
Binding Site
20%
Nude Mouse
20%
Immunoglobulin G1
20%
Internalization
20%
Tumor Antigen
20%
Iodine-131
20%
Rhabdomyosarcoma Cell Line
20%
Muscle
20%
In Vitro
20%
Lung
20%
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
100%
Rhabdomyosarcoma
100%
Iodine-125
71%
Neoplasm
42%
Biodistribution
14%
Binding Site
14%
Immunoglobulin G1
14%
Nude Mouse
14%
Tumor Antigen
14%
Iodine-131
14%
Chemotherapy Regimens
14%